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Abstract
Mitochondria change distribution across cells following a variety of pathophysiological stimuli. The mechanisms presiding over
this redistribution are yet undefined. In a murine model overexpressing Drp1 specifically in skeletal muscle, we find marked
mitochondria repositioning in muscle fibres and we demonstrate that Drp1 is involved in this process. Drp1 binds KLC1 and
enhances microtubule-dependent transport of mitochondria. Drp1-KLC1 coupling triggers the displacement of KIF5B from
kinesin-1 complex increasing its binding to microtubule tracks and mitochondrial transport. High levels of Drp1 exacerbate this
mechanism leading to the repositioning of mitochondria closer to nuclei. The reduction of Drp1 levels decreases kinesin-1
activation and induces the partial recovery of mitochondrial distribution. Drp1 overexpression is also associated with higher
cyclin-dependent kinase-1 (Cdk-1) activation that promotes the persistent phosphorylation of desmin at Ser-31 and its
disassembling. Fission inhibition has a positive effect on desmin Ser-31 phosphorylation, regardless of Cdk-1 activation,
suggesting that induction of both fission and Cdk-1 are required for desmin collapse. This altered desmin architecture impairs
mechanotransduction and compromises mitochondrial network stability priming mitochondria transport through microtubule-
dependent trafficking with a mechanism that involves the Drp1-dependent regulation of kinesin-1 complex.
Introduction
Mitochondria play a key role in cellular homoeostasis and
the proper regulation of mitochondrial transport ensures
their position at sites where energy demands or oxygen
supplies are the greatest [1]. Consequently, mitochondria
can redistribute in response to shifts in local energy
demands [2–4]. Long-range mitochondrial transport pri-
marily involves microtubules (MT) and their specific
motors (kinesins and dynein), whereas the actin cytoskele-
ton and its associated myosin motors support the short-
range mitochondrial movement and the actin-dependent
mitochondrial anchoring [5, 6].
In muscle cells, mitochondria use MT and intermediate
filaments (IF) for their movement and proper localisation
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[7] and KIF5B mostly aids the mitochondrial transport
along MT in myoblasts [8]. Conversely, IF do not provide
directional transport [9] but arrest and anchor mitochondria
in the specific cellular locations where they are required
[10, 11]. Consistently, lack of desmin results in perturba-
tions of mitochondrial positioning with subsarcolemmal
aggregation of mitochondria [12]. The same occurs in the
absence of IF–microfilament cross-linkers [11, 13, 14]
supporting the evidence that IF alterations can change
mitochondrial morphology and localisation.
In a mouse model overexpressing dynamin-related pro-
tein 1 (Drp1) specifically in skeletal muscle (Drp/MyoDiCre
(Drp/MC) mice), we found a reduction of muscle mass
mainly caused by significant decrease in the weight of
glycolytic muscles and a significant perturbation of mito-
chondrial distribution with the postnatal mitochondrial
network remodelling not occurring properly and mito-
chondrial distribution being drastically redistributed
towards the myonuclei leading to fibres with cytoplasmic
region completely devoided of mitochondria [15]. Drp1
mediates mitochondrial fission [16] and its regulation is
critical for myogenesis to occur [17]. A role for Drp1 in
mitochondrial trafficking has never been described.
Here, we demonstrate that high Drp1 levels promote
mitochondrial repositioning by activating the kinesin-1
complex. Kinesin-1 is a tetramer consisting of a homodimer
of one kinesin heavy chain (KIF5A, KIF5B or KIF5C) and
two kinesin light chains (KLC1 and KLC2). KIF5A and
KIF5C are neuron-specific, whereas KIF5B is ubiquitously
expressed [18].
We find that Drp1 binds KLC1 releasing KIF5B from
kinesin-1 complex allowing its association with MT and
leading to transport of mitochondria. We also demonstrate
that Drp1 and fission are responsible for desmin collapse
that in turn triggers the subsarcolemmal mitochondria
clumping. Based on our results we propose a model
whereby high Drp1 levels are responsible for desmin dis-
ruption and KIF5B-mediated transport of mitochondria
involving both Cdk-1 activation and Drp1-KLC1 coupling.
These mechanisms could be relevant in some human con-
ditions, such as central core disease and myofibrillar myo-
pathies where Drp1 is upregulated, the relevance of which
also in therapeutic perspectives deserves being studied.
Materials and methods
Animals
All procedures involving mice were performed in accor-
dance with the Italian law on animal care (D.L. 26/2014), as
well as European Directive (2010/63/UE) and animal
experimentation was approved by the Ministero della Salute
(approval no. 1124/2015-PR). We used the minimal number
of mice sufficient for determining significant differences in
each cohort.
Mice (FBV/N C57BL/6 background) were generated as
described in the previous paper [15] and were used between
7–100 days after birth compared with age-matched litter-
mates. Mice were chosen randomly from a pool of geno-
typed mice at appropriate ages. Within each cohort, animals
were chosen to balance the number of male and female mice
in the groups and could derive from different parents.
Transgenic mice were identified by PCR analysis of tail
DNA using the following primers:
TgDrp1 Fw: 5′ GCA TTA CAA GGA GCC AGT CAA
3′; Rev: 5′ CAC CCT CAA AGG CAT CAC C 3′.
MyoDCre Fw1: 5′ GGC TCT CTC TGC TCC TTT GA 3′;
Fw2: 5′ GCG GAT CCG AAT TCG AAG TTC C 3′; Rev:
5′ TGG GTC TCC AAA GCG ACT CC 3′. Pham WT Fw
5′ CCA AAG TCG CTC TGA GTT GTT ATC 3′; Rev: 5′
GAG CGG GAG AAA TGG ATA TG 3′. Pham Mutant Fw
5′ CCC CAA CGA ATG GAT CTT G 3′; Rev: 5′ TTC
GAG GGA CCT AAT AAC TTC G 3′.
Animals were maintained under controlled conditions
(temperature 20 ± 2 °C; 12-hour light-dark cycle) with food
and water provided ad libitum.
Mdivi-1 (Sigma-Aldrich, St. Louis, MO, USA) 12.5 mg/
kg [19] or vehicle was intraperitoneally injected daily for
8 weeks in P25 mice. Mdivi-1 was dissolved in a 5:5:90
DMSO/cremophor/PBS vehicle and no significant differ-
ences in food and water intake were observed among the
experimental groups.
For exercise experiments, mice were subjected to tread-
mill running at 15 m/min for 45 min [20]. Three hours after
exercise, skeletal muscles (gastrocnemius) were isolated
and analysed by real-time PCR.
Human muscle samples
Central core and myofibrillar myopathy muscle bioptic
tissues were provided by the Bank of muscle tissue, per-
ipheral nerve, DNA and cell culture at Fondazione IRCCS
Ca’ Granda, Ospedale Maggiore Policlinico (Milano, Italy),
which is part of the Telethon Network of Genetic Biobank.
Myotubes generation
Myotubes were obtained after satellite cells differentiation.
Satellite cells (SC) were prepared from glycolytic muscles
following a standardised, automated tissue dissociation
protocol with a gentleMACS™ Octo Dissociator with
Heaters (Miltenyi Biotec, Bergisch Gladbach, Germany)
and magnetic depletion as previously reported [21].
To generate myotubes, SC were cultured on Matrigel-
coated (BD Biosciences, San Jose, CA, USA) coverslips in
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DMEM (EuroClone, Pero, Milan) supplemented with 20%
foetal bovine serum (EuroClone), 3% chick embryo extract
(custom made), 10 ng/ml basic fibroblast growth factor
(PeproTech, London, UK) and 1% penicillin-streptomycin
(EuroClone) at 37 °C with 5% CO2 for two days to reach
the sufficient cells density to promote myogenic differ-
entiation. Myogenic differentiation was induced in DMEM
supplemented with 2% horse serum (EuroClone) and 1%
penicillin-streptomycin (EuroClone) and after 48 h myo-
tubes were analysed.
For some experiments, myotubes after 24 h in differ-
entiation medium were supplemented with Mdivi-1 1 µM
[22] in DMSO and analysed after 24 h.
Myofibre isolation and culture
Single myofibres were isolated from TA muscles of P7,
P25 and P100 mice as previously described [23]. Briefly,
TA muscles were dissected and incubated in DMEM
(EuroClone) containing 0.2% collagenase I (Sigma-Aldrich)
for 1 h. Myofibres were obtained using gentle flushing with
a glass pipette and washed several times with DMEM, then
they were fixed with 4% paraformaldehyde (PFA) for 10
min immediately after isolation.
Proximity ligation assays (PLA)
Single myofibres or muscle sections were fixed (4% par-
aformaldehyde in PBS pH 7.5) and permeabilised (0.1%
Triton X-100, 0.1M Glycine, PBS) for 10 min. Permeabi-
lised samples were blocked with the Duolink Blocking
Solution (Sigma-Aldrich) for 3 h. Primary antibodies pre-
pared in Duolink Blocking Solution (Sigma-Aldrich) were
incubated overnight at 4 °C, then PLA reactions were run
using the Duolink PLA probes for mouse and rabbit and
Duolink In Situ Detection Reagents Red (Sigma-Aldrich),
following the manufacturer’s protocol. After some wash
steps, myofibres were mounted on glass slides with Vec-
tashield Antifade Mounting Medium with DAPI (Vector
Laboratories, Burlingame, CA, USA).
Quantification of PLA was performed by counting PLA
puncta per fibres and whole muscle sections. PLA experi-
ments were performed in TA myofibres isolated from 3
different mice after which a minimum of 15 myofibres or
15 sections were analysed.
Quantitative real-time PCR analysis
RNA was isolated from muscles using TRIzol (Thermo-
Fisher Scientific, Waltham, MA, USA) according to already
published protocols [24]. Briefly, total RNA (1 µg) was retro-
transcribed using the Script Reverse Transcription Supermix
(Bio-Rad, Hercules, CA, USA). RT-qPCR was performed
using the g SsoAdvanced Universal SYBR Green Supermix
(Bio-Rad) and the CFX96 Touch Real-Time PCR Detection
System (Bio-Rad). All reactions were run as triplicates and
the fold changes determined relative to the 36B4 house-
keeping transcripts using the 2−ΔΔCT formula [25].
For mtDNA analysis, total genomic DNA was isolated by
using the QIAamp DNA Micro kit (Qiagen, Hilden, Ger-
many). The amount of mtDNA per nuclear genome was
measured by qPCR using specific primers for cytochrome b
and RNase P. mtDNA quantification of the relative copy
number per nuDNA was analysed using the 2−ΔΔCT formula.
Below the list of primers:
Cyt b Fw: 5′ ACG CCA TTC TAC GCT CTA TC 3′;
Rev: 5′ GCT TCG TTG CTT TGA GGT GT 3′. RNase P
Fw: 5′ GAA GGC TCT GCG CGG ACT CG 3′; Rev: 5′
CGA GAG ACC GGA ATG GGG CCT 3′. 36B4 Fw: 5′
AGG ATA TGG GAT TCG GTC TCT TC 3′; Rev: 5′ TCA
TCC TGC TTA AGT GAA CAA ACT 3′. PGC-1α Fw: 5′
TCT GAG TCT GTA TGG AGT GAC AT 3′; Rev: 5′ CCA
AGT CGT TCA CAT CTA GTT CA 3′. Slc3a2 Fw: 5′
GGG GAG CGT ACT GAA TCC CT 3′; Rev: 5′ CTG
AAG GCC AAG CTC ATC CC 3′. Slc6a9 Fw: 5′ GTT
GGC GCT TTG TTT CTC CG 3′; Rev: 5′ TCT GCT TGG
CTT TGT GGC AT 3′. Mthfd2 Fw: 5′ CAT GGG GCG
TGT GGG AGA TAA T 3′; Rev: 5′ CCG GGC CGT TCG
TGA GC 3′. Asns Fw: 5′ ATT ACG ACA GTT CGG GCA
TC 3′; Rev: 5′ TCT CAG TTC GAG ACC GTG TG 3′.
Gadd45a Fw: 5′ CGG TGA TGG CAT CCG AAT GGA
AAT 3′; Rev: 5′ TCT GCA AAG TCA TCT CTG AGC
CCT 3′. P21 Fw: 5′ CAA AGT GTG CCG TTG TCT CT
3′; Rev: 5′ GTC AAA GTT CCA CCG TTC TC 3′. KLC1
Fw: 5′ AGC GGG AGT TTG GAT CTG TG 3′; Rev: 5′
AGC CAC TCT CTG CTT ACG TGA 3′. KIF5B Fw: 5′
GCG GAG TGC AAC ATC AAA GTG 3′; Rev: 5′ CAT
AAG GCT TGG ACG CGA TCA 3′.
Immunoblotting
Proteins were extracted from muscles and myotubes. Mus-
cles were homogenised in a lysis buffer containing 20 mM
Tris-HCl (pH 7.4), 10 mM EGTA, 150 mM NaCl, 1%
Triton X-100 (Sigma-Aldrich, X100), 10% glycerol, 1%
SDS (Sigma-Aldrich, L3771) supplemented with a cocktail
of protease and phosphatase inhibitors (cOmplete and
PhosSTOP; Sigma-Aldrich) with an Ultra-Turrax (Ika
Werke GmbH & Co). Myotubes lysis was performed in the
RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl,
0.1% SDS (Sigma-Aldrich), 1% NP-40 (Sigma-Aldrich),
0.25% sodium deoxycholate (Sigma-Aldrich), 1 mM
EDTA) supplemented with protease and phosphatase inhi-
bitors. After centrifugation at 10,000 × g for 10 min, pro-
teins were quantified with the Bio-Rad protein assay after
which 30–50 µg were loaded on 4–20% polyacrylamide
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precast gels (Criterion TGX Stain-free precast gels; Bio-
Rad). Proteins were transferred onto a nitrocellulose mem-
brane using a Trans-Blot Turbo SystemTM (Bio-Rad) and
Transfer packTM (Bio-Rad). The revelation was carried out
by specific horseradish peroxidase-labelled secondary anti-
bodies (Bio-Rad), followed by chemiluminescent detection
(Bio-Rad) with the ChemiDoc MP imaging system (Bio-
Rad). The blots were routinely treated with glycine (0.2 M
pH 2.5) stripping buffer and reprobed.
For the preparation of extracts to detect desmin and
desmin tetramers, fresh TA muscles were dissected and
homogenised with an Ultra-Turrax in ice-cold extraction
buffer containing 50 mM Tris–HCl pH 8, 50 mM NaCl, 5
mM EDTA, 5 mM EGTA, 0.5% NP‐40, 0.05% SDS. After
30 min of incubation on ice, the extracts were centrifuged
for 30 min at 30,000 rpm at 4 °C. After centrifugation,
pellets were freeze-thawed twice, homogenised in a small
volume and centrifuged for 30 min at 30,000 rpm at 4 °C.
Finally, the supernatants were pooled and quantified for
immunoblotting.
Immunoprecipitation
For immunoprecipitation experiments, muscles were
homogenised with an Ultra-Turrax (Ika Werke GmbH &
Co, Staufen, Germany) in a lysis buffer containing 20 mM
Tris–HCl pH 8, 137 mM NaCl, 10% Glycerol, 1% NP‐40,
2 mM EDTA, protease and phosphatase inhibitor cocktail
(cOmplete and PhosSTOP; Sigma-Aldrich). Lysates were
cleared by centrifugation and the same amount of proteins
were incubated overnight with either the specific primary
antibodies and the appropriate protein A or protein G
Sepharose (GE Healthcare, Chicago, IL, USA) beads.
Beads were washed three times in lysis buffer and eluted in
Laemmli buffer. The whole‐lysate (input) and the immu-
noprecipitated (IP) samples were separated by SDS–PAGE,
transferred to nitrocellulose membranes, incubated with the
proper antibodies, and developed according to standard
procedures described above.
Immunofluorescence
Muscles were dissected and immediately frozen in liquid
N2-cooled isopentane (Sigma-Aldrich) to allow the pre-
paration of 5 μm thick sections, while single fibres were
prepared as described above.
For immunofluorescence, we followed a standard pro-
tocol [26] for both muscle sections and single fibres. In
brief, samples were fixed with PFA (Sigma-Aldrich) 4% for
10 min and permeabilised with 0.1% TritonX-100 (Sigma-
Aldrich) in PBS (EuroClone). Sections were then blocked for
30min in blocking buffer containing 2% normal goat serum
(NGS; Vector Laboratories), 0.5 % bovine serum albumin
(BSA) and PBS (EuroClone). All primary antibodies were
diluted in blocking buffer and incubated at room temperature
for 2 h. Samples were subsequently washed three times with
PBS and incubated with fluorophore-conjugate (Alexa Fluor
conjugates, ThermoFisher) secondary antibodies for 1 h at
room temperature after which nuclei were counterstained
with DAPI (ThermoFisher Scientific). Slides were finally
mounted with the ProLong Gold antifade reagent (Thermo-
Fisher Scientific).
Antibodies and reagents
The following antibodies were used: antibodies against
Drp1 (D6C7) (#8570S; WB 1:1000, IF 1:100, IP/PLA
1:100), P-Drp1(S616) (#3455S; WB 1:1000), P-Drp1
(S637) (#4867S; WB 1:1000), Desmin (D93F5) (5332S;
WB 1:1000, IF 1:100), eIF2alpha (#9722S; WB 1:1000)
and P-eIF2alpha (S51) (#9721; WB 1:1000), Cdc2 (#28439;
WB 1:1000) and P-Cdc2 (Thr161) (#9114; WB 1:1000)
which were purchased from Cell Signaling Technology
(Beverly, MA, USA); antibodies against KLC1 (L2) (sc-
58776; WB 1:500 IF 1:100) and GAPDH (FL-335) (sc-
25778; WB 1:3000) which were purchased from Santa Cruz
Biotechnology (Dallas, TX, USA); antibodies against alpha-
Tubulin (ab11304-100; IF/PLA 1:100), KIF5B (ab167429;
WB 1:1000, IF/PLA 1:200, IP 1:100), and KLC1
(ab174273; IF/PLA 1:100) which were purchased from
Abcam (Cambridge, UK); an antibody against DLP1 (i.e.
Drp1) (611113: WB 1:800) which was purchased from BD
Biosciences; antibodies against Desmin (D1033; WB
1:500) and Clpp (WH0008192M1; WB: 1:1000) which
were purchased from Sigma-Aldrich; an antibody against
OxPhos Complex IV subunit IV (i.e. COX IV) (20E8C12;
WB 1:2000, IF 1:50) which was purchased from Invitrogen
(Carlsbad, CA); the antibody against p-desmin Ser-31
(#D375-3; WB 1:1000, IF 1:500) was purchased from MBL
Life Science (Woburn, MA, USA).
Microtubules spin-down assay
MT binding assay was performed using the MT-binding
protein spin-down assay kit (Cytoskeleton, Denver, CO,
USA) following the manufacturer’s instructions. For protein
extracts, fresh gastrocnemius muscles were homogenised
using an Ultra-Turrax in a PIPES-based buffer (80 mM
PIPES, 1 mM EGTA, 1 mM MgCl2, 0.3% Triton X-100,
10% glycerol, supplemented with a cocktail of protease and
phosphatase inhibitors). For the spin-down procedure,
in vitro polymerised MT were incubated for 30 min at room
temperature with 8 μg of purified MAP2, 3 μg of BSA or
100 μg of the muscle protein extracts described above. As a
control, the proteins were incubated in the absence of MT.
MT (pellet fraction: P) and soluble proteins (supernatant
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fraction: S) were then separated by ultra-centrifugation at
100,000 × g at room temperature for 40 min using a cushion
buffer. To remove the high amount of tubulin, pelleted
fractions were incubated with the Salt Extraction Buffer
provided by the manufacturer following ultra-centrifugation
at 100,000 × g at room temperature for 40 min for the
salting-off procedure; this step ensures the dissociation
between MT and MT-binding proteins. Subsequently, the
proteins were precipitated via a trichloroacetic acid (TCA)
extraction: the TCA solution (1:10) was added to the sam-
ples and incubated 15 min on ice. Following centrifugation
at 14,000 rpm for 10 min at 4 °C the pellet was resuspended
in 1M Tris-base, pH 10.4. S and purified P fractions were
loaded onto 4–20% polyacrylamide precast gels and ana-
lysed for the presence of KIF5B, Drp1 and KLC1 by
immunoblotting.
Image acquisition and analysis
Confocal imaging
Confocal images were acquired on a Leica TCS SP8 System
equipped with a Leica DMi8 inverted microscope, using a
Leica HC PL APO CS2 40X/1.30 oil immersion objective.
Samples were illuminated with 405 nm laser line for the
detection of DAPI signal and 561 nm tuned with light laser
for the detection of both Cy3 signal and DIC image. The
acquisition software used was the Leica Application Suite
X, ver. 3.5.2.18963 (Leica, Wetzlar, Germany). An image
format of 1024 × 1024 pixel was used and both optical
zoom ×1 and ×2 were used for the samples acquisition.
For three-dimensional reconstruction of mitochondria,
0.5 μm thick Z-stacks were acquired using a Leica TCS SP8
System equipped with a Leica DMi8 inverted microscope;
three-dimensional projections were generated using the
Leica LAS X software.
Time-lapse imaging
Time-lapse imaging was performed on myotubes and
muscle fibres.
For myotubes, time-lapse movies were recorded using a
Confocal Spinning Disk microscope (Olympus, Shinjuku,
Tokyo, Japan) equipped with an IX83 inverted microscope
provided with an IXON 897 Ultra camera (Andor, Belfast,
UK), using a 60× UPlanSApo 1.35NA objective. The sys-
tem is driven by the Olympus CellSens Dimension
1.18 software (Build 16686). Temperature, CO2 con-
centration and humidity were controlled using an OKOlab
incubator. FITC signals were excited with a 488 nm 50 mW
diode lasers. Eight or 10 min time-lapse movies were
recorded with a 10 s time-frame setting.
Time-lapse movies on muscles were recorded using an
UltraVIEW VoX spinning-disk confocal system (Perki-
nElmer, Waltham, MA, USA) equipped with an EclipseTi
inverted microscope (Nikon, Minato, Tokyo, Japan)
provided with a Yokogawa CSU-X1 confocal scanner
unit, an integrated FRAP PhotoKinesis module (Perki-
nElmer), a Hamamatsu CCD camera (C9100-50) and
driven by the Volocity software ver. 6.3.1 (Improvision;
Perkin Elmer). All images were acquired through a 60×
oil-immersion objective (Nikon Plan Apo VC, NA 1.4).
Temperature, CO2 concentration and humidity
were controlled using an OKOlab incubator. Ten minutes
time-lapse movies were recorded with a 2 s time-frame
setting.
The photoconversion experiments on muscle were per-
formed using the 405 nm laser. GFP and mCherry signals
were excited respectively with a 488 nm and 561 nm 50
mW diode lasers.
Mitochondria morphometric analysis
An Image J macro was used to quantify mitochondria
morphology [27, 28]. The green channel of PhAM myo-
tubes was extracted to grayscale, thresholded to resolve
optimally individual mitochondria and converted to a binary
image. For the analysis of mitochondrial branching, the
binary image was converted to a skeleton by using “skele-
tonise”. Finally, the length of each branch and the number
of branches were determined by using the “analyse skele-
ton” plugin.
Analysis of mitochondrial distance travelled
Time-lapse sequences were imported into ImageJ after which
individual mitochondria were manually tracked using the
Manual Tracking plugin. Mitochondria were tracked along
the stacks and the distance between frames was used to
calculate the cumulative distance travelled by each individual
mitochondria. At least ten mitochondria for myotubes were
tracked and the experiment was repeated three times.
Mitochondrial displacement index
Mitochondrial displacement was quantified by calculating
the ratio between the area of the maximum projection of the
fluorescence intensity and the area of the fluorescence
intensity of the mitochondria network on the first frame.
The obtained ratio represents the fraction of mitochon-
drial mass that changed position over time. We developed a
custom Fiji Plugin [29] to obtain the two areas and their
relative ratios. Data were obtained from three independent
experiments.
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MyToe analysis
Maps of the instantaneous mitochondrial velocities
were obtained by analysing time-lapse movies (on
the FITC channel) and performing an Optical Flow ana-
lysis using a Mytoe Software on pre-selected cell
regions [30].
The instantaneous rootmeans square velocity Vr.m.s(t) of a
single region for each time point t, was calculated as
Vr:m:s: tð Þ ¼ 1Nvalid
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
X
Nvalid
n¼ 1
jv xn; tð Þj2
v
u
u
t ;
where Nvalid is the number of grid points in the
mitochondrial region (obtained automatically from the
software) and v xn; tð Þ is the instantaneous velocity at the
nth grid point xn with jv xn; tð Þj2 > 7 nm/s.
The analysis was performed on three independent
experiments per condition.
Statistics
We have not used a statistical method to predetermine
samples size. Sample size was chosen according to our
experience with biochemical and in vivo experiments and
no samples were excluded from the analysis. The experi-
ments were not carried out in blinding conditions and the
results were shown as mean ± SEM if not otherwise indi-
cated. A GraphPad Prism (GraphPad Software, Inc) was
used to analyse the data. The D’Agostino and Pearson
omnibus test was applied to assess normal distribution of
data. Comparison of two groups normally distributed was
performed using an unpaired two-tailed t-test while non-
normally distributed data were analysed with the
Mann–Whitney test. Comparison of multiple groups was
performed by one-way ANOVA followed by post hoc
Tukey’s test. For grouped analyses, two-way ANOVA with
correction for multiple comparisons using the Holm–Sidak
method was used. A P value < 0.05 was considered
significant.
Results
Drp1 is more active in Drp/MC mice leading to
progressive alterations of mitochondrial network
Overexpression of Drp1 in Drp/MC mice affects the normal
remodelling of the mitochondrial network by redistributing
mitochondria closer to the sarcolemma and/or myonuclei
[15]. A mild defect is present already in growing muscle
starting at P7 (P, postnatal day) to become more evident in
the adult muscle at P100.
The balance between Drp1 Ser-616/Ser-637 phosphor-
ylation reflects Drp1 activity [31, 32]. In Drp/MC transgenic
mice we found a significant increase in Drp1 phosphor-
ylation at Ser-616 combined with a decreased phosphor-
ylation at Ser-637, indicating a hyperactivation of Drp1
(Fig. 1a). This was paralleled by an increased association of
Drp1 with mitochondria suggesting a pro-fission state of
mitochondria. Despite this, mitochondrial Drp1 localisation
was only partial as clearly shown by its high residual levels
in the cytosolic fraction (Fig. 1b).
To analyse further this aspect we took advantage of mice
with photo-activatable mitochondria (PhAM mice) which
were crossed with wild-type (WT) and Drp/MC mice [15]
and allowed us to perform a 3D reconstruction of the
mitochondrial network in single fibres. Normal fibres
reported the typical striated distribution of intermyofibrillar
and subsarcolemmal mitochondria (Fig. 1c, left panels),
whereas Drp1-overexpressing fibres from an early stage of
development (P7) showed a disorganised mitochondrial
network characterised by isolated ellipsoid‐shaped mito-
chondria (Fig. 1c, upper panels). At P25 an initial redis-
tribution of fissioned mitochondria towards the sarcolemma
became apparent (Fig. 1c, middle panels) and at P100,
regions of cytoplasm completely devoided of mitochondria
were observed (Fig. 1c, lower panels).
In Drp/MC mice the postnatal mitochondrial biogenesis
occurred to a lesser extent compared with WT and after P25
the mitochondrial content in Drp/MC mice did not change
further (Fig. 1d). By contrast, mitochondrial DNA
(mtDNA) levels increased progressively with age in WT
mice (Fig. 1d). Consistently, peroxisome proliferator-
activated receptor-gamma coactivator 1 α (PGC-1α), the
master regulator of mitochondrial biogenesis [33], had a
peak of expression at P25 in WT mice that was milder in
Drp/MC mice (Fig. 1e), confirming a reduced induction of
mitochondrial biogenesis during muscle postnatal growth.
Conversely, after a bout of forced exercise, both WT and
transgenic mice upregulated PGC-1α without differences
between genotypes (Fig. 1f), indicating that the mitochon-
drial biogenesis machinery is not affected in Drp/MC mice,
rather, it is defectively stimulated by an impaired postnatal
muscle growth [15]. This finding, alongside with the
mitochondrial repositioning we observed, is not surprising
as mitochondria are transported to optimise ATP delivery
[34]. We thus investigated whether Drp1 was responsible
for the mitochondrial repositioning in Drp/MC mice.
Drp1 regulates microtubule-dependent
mitochondrial trafficking
Mitochondria primarily move along MT tracks, an action
that requires their coupling with motor proteins [18].
As muscle cells require the kinesin-1 complex for
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mitochondrial movements [8] we investigated its role in
Drp/MC muscle. At P1 and P7, when the mitochondrial
trafficking was absent, the levels of KIF5B and KLC1 were
unchanged in Drp/MC muscle (Fig. S1A). However, at P25,
when the repositioning of mitochondria was at its begin-
ning, KIF5B and KLC1 protein levels were efficiently
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upregulated in Drp/MC muscles (Fig. S1B). Conversely, at
P100, when the repositioning of mitochondria had already
occurred, only KIF5B was still higher; by contrast, the
levels of KLC1 were similar to those observed in WT
(Fig. S1C). Considering that KIF5B and KLC1 expressions
were similar in WT and Drp/MC mice at both P25 and P100
(Fig. S1D), their increase appears consistent with translation
or post-translation regulation.
In agreement with the increased amount of kinesin-1
complex, at P25 mitochondria in Drp/MC/PhAM fibres
exhibited a faster speed of movements with evident changes
in mitochondrial position over a 10 min period as assessed
by time-lapse imaging experiments in muscle fibres after
mitochondria photoconversion (Fig. 2a and Video 1).
To assess further the role of Drp1 overexpression in the
mitochondrial movement we used myotubes derived from
primary myoblasts isolated by sorting from WT/PhAM and
Drp/MC/PhAM muscles. In agreement with the results
obtained in fibres, we observed a disorganised and frag-
mented mitochondrial network, suggesting that myotubes
could mimic in vivo condition (Fig. S2A). Drp1 over-
expression significantly increased mitochondrial displace-
ment index measured as the fraction of mitochondrial mass
that changed position between frames during the time
[35, 36] (Fig. 2b and Video 2). Therefore, mitochondria in
Drp-overexpressed myoblasts displayed high capability of
redistribution during a short period (Fig. S2B). They also
exhibited high fluctuations in instantaneous velocity, mea-
sured through Mytoe software [30], reaching a maximum of
80 nm/sec, whereas the instantaneous velocities in WT
myotubes were lower and relatively constant (Fig. 2c).
Mitochondrial movement is mediated by the actin
cytoskeleton for short-range displacements and the MT
cytoskeleton for longer range movements [35]. In muscle,
MT form a non-classic grid-like network [37] that was
unaffected by Drp1 overexpression (Fig. S3A, B) as well as
the actin microfilaments (MF) (Fig. S3A, B), confirming the
possibility for mitochondria to move along the cytoskeleton.
Consistently, we detected a directional displacement of
mitochondria in Drp/MC myotubes covering a longer dis-
tance (µm) over a 10 min period compared with WT myo-
tubes (Fig. 2d, Fig. S3C and Video 3), indicating a boosted
MT-mediated transport of mitochondria.
Drp1 sequesters KLC1 allowing transport of
mitochondria by KIF5B
The enhanced directional mitochondrial movements in the
presence of high levels of Drp1 would suggest its invol-
vement in the regulation of the kinesin-1 complex. Drp1 has
been recognised as a novel binding partner for KLC1 [38].
In Drp/MC muscle homogenates, Drp1 clearly pulled down
KLC1, but not KIF5B, indicating that KIF5B is not in the
same complex with Drp1 and KLC1 (Fig. 3a). Similarly,
KIF5B did not pull down Drp1 (Fig. 3a), confirming that
the Drp1-KLC1 complex is formed regardless of KIF5B.
To confirm the specificity of Drp1 and KLC1 binding,
we performed the Drp1:KLC1 proximity ligation assay
(PLA) on muscle sections and single muscle fibres and we
detected enhanced PLA signal in Drp/MC mice (Fig. 3b).
Of note, PLA puncta did not colocalise with mitochondria
indicating that only the cytosolic fraction of Drp1 was able
to interact with KLC1 (Fig. 3b). The involvement of cyto-
solic Drp1 in Drp1-KLC1 complex was further supported
by fractionation experiments, in which KLC1 was found
only in the cytosol (Fig. S3D) while Drp1 could be detected
in both the mitochondrial and cytosolic fractions (Fig. 1b).
Transport of mitochondria along the axon may not require
KLC1 [39]. Whether this is the case also in muscle it is
unknown. To explore this issue we assessed the amount of
kinesin-1 in the active state, looking at the components of the
complex associated with MT [40]. To this end, we performed
the MT spin-down assay with WT and Drp/MC muscle
homogenates. Only KIF5B co-sedimented with MT while
Drp1 and KLC1 were enriched in the unbound fraction
(Fig. 3c), confirming that the active form of kinesin-1
involves only its heavy chain KIF5B, but not the tetramer.
Moreover, kinesin-1 was more active in Drp1 overexpressing
muscle, where more KIF5B co-sedimented with MT.
In agreement with this evidence, the KIF5B:α-tubulin
PLA signal was higher in Drp/MC sections and single fibres
when compared with those of the WT (Fig. 3d); otherwise
Fig. 1 Drp1 overexpression impacts on mitochondrial content,
positioning and remodelling. a Representative immunoblotting of
phospho-Drp1 on serine 616 (p-Drp1-S616) and serine 637 (p-Drp1-
S637) and total Drp1 in Tibialis Anterior (TA) lysates from WT and
Drp/MC mice at P25. Phosphorylated Drp1 levels normalised on total
Drp1 were quantified and shown as fold change of WT (n ≥ 7 mice per
genotype). * vs WT (**P < 0.01). b Representative immunoblotting of
Drp1 in mitochondrial and cytosolic fractions of TA from WT and
Drp/MC mice at P25. COX IV and GAPDH have been used as
mitochondrial and cytosolic markers respectively. c Confocal images
(left) and magnified 3D reconstructions (right) of TA muscle fibres
from WT/PhAM and Drp/MC/PhAM at P7, P25 and P100 showing
mitochondrial network (green) (scale bar= 10 µm). d Quantitative
PCR (qPCR) analysis of mtDNA content in TA from WT and Drp/MC
mice at P7, P25 and P100. DNA levels were quantified and shown as
fold change of P7 WT (n ≥ 3 mice per genotype). * vs WT at P7 (***P
< 0.001);+ vs Drp/MC at P7 (+++P < 0.001); § vs WT at P25 (§P <
0.05, §§§P < 0.001); ° vs WT at P100 (°°°P < 0.001). e Quantitative
Reverse Transcription PCR (RT-qPCR) analysis of PGC-1α in gas-
trocnemius from WT and Drp/MC mice at P7, P25 and P100. Data are
shown as fold change of P7 WT (n ≥ 4 mice per genotype). * vs WT at
P7 (*P < 0.05, ***P < 0.001); +vs Drp/MC at P7 (+P < 0.05); § vs
WT at P25 (§P < 0.05). f RT-qPCR analysis of PGC-1α in gastro-
cnemius from WT and Drp/MC mice at P100 either sedentary or
trained. Data are shown as fold change of sedentary WT (n ≥ 3 mice
per condition). * vs sedentary WT (***P < 0.001); +vs sedentary Drp/
MC (+++P < 0.001). Values are expressed as mean ± SEM.
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no signal was detected for KLC1:α-tubulin PLA (Fig. S3E),
confirming that the active binding of KIF5B on MT does
not require KLC1 and that kinesin-1 is more active in Drp1
overexpressing muscles.
To assess whether Drp1 is involved in the activation of
kinesin-1 complex, we treated Drp/MC mice at P25 with a
daily intraperitoneal injection of the Drp1 inhibitor Mdivi-1
for 8 weeks. In Drp/MC mice Mdivi-1 induced a 40%
Fig. 2 Drp1 overexpression increases mitochondrial movements. a
Stills from the movie showing mobility of WT/PhAM and Drp/MC/
PhAM mitochondria (TA). Arrowheads indicate mitochondrial
movements during the time (scale bar= 5 µm). b Stills from movies
showing the area occupied by mitochondria in WT and Drp/MC
myotubes at 10 s (magenta) and after 600 s (blue) (scale bar= 5 µm).
Displacement Index was calculated (n ≥ 3 independent experiments). *
vs WT (**P < 0.01). c Instantaneous velocities of mitochondria in
selected ROI were determined in WT and Drp/MC myotubes using
Mytoe software (n ≥ 3 independent experiments). d Distance travelled
by mitochondria in WT and Drp/MC myotubes calculated by ImageJ
software (n ≥ 3 independent experiments n ≥ 20 mitochondria). * vs
WT (***P < 0.001). Values are expressed as mean ± SEM.
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Fig. 3 Drp1 binds KLC1 and affects kinesin-1 activation. a Co-
immunoprecipitation of Drp1, KIF5B and KLC1 in TA lysates from
WT and Drp/MC mice at P25. Control immunoglobulins (cIgG) were
used as IP negative control. b Representative Drp1:KLC1 PLA (red
puncta) on TA sections (left panel) and single fibres (right panel) from
WT/PhAM and Drp/MC/PhAM (scale bar= 25 µm for both section
and fibre). COX4-FITC (green) and DAPI (blue) signals (scale bar=
20 µm) and PhAM fibre magnification are provided. PLA puncta were
quantified and shown as a percentage relative to WT (n= 3 mice per
genotype). c Microtubules (MT) spin-down assay using TA lysates
from WT and Drp/MC mice at P25 incubated with (+) or without (−)
polymerised Tubulin. Pellet (P) and supernatant fractions (S) were
analyzed by immunoblotting for KIF5B, Drp1 and KLC1. After
salting-off procedure, detectable tubulin residues are still visible in P
fractions (stain-free gel). d Representative KIF5B:α-Tubulin PLA (red
puncta) on TA sections (left panel) and single fibres (right panel) from
WT/PhAM and Drp/MC/PhAM (scale bar= 25 µm for both section
and fibre). COX4-FITC (green) and DAPI (blue) signals (scale bar=
20 µm) and PhAM fibre magnification are provided. PLA puncta were
quantified and shown as a percentage relative to WT (n= 3 mice per
genotype). Values are expressed as mean ± SEM. * vs WT (*P < 0.05,
***P < 0.001).
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recovery of fibres with normal SDH staining (Fig. 4a)
accompanied by a more organised mitochondrial network
without region devoided of mitochondria (Fig. S4A).
Moreover, Mdivi-1 increased mitochondrial branch length
compared with untreated Drp1/MC mice (Fig. S4B). These
changes were not coupled to mtDNA recovery (Fig. S4C)
supporting a role of Drp1 only in the maintenance of normal
mitochondria positioning and in the regulation of mito-
chondrial trafficking. Accordingly to Manczak et al. [41],
we found a significant Mdivi-1-dependent drop of Drp1
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levels in muscle (Fig. 4b). By contrast, Mdivi-1 did not
reduce the expression of both KIF5B and KLC1 (Fig. S4D).
We confirmed these findings in myotubes treated for 24 h
with Mdivi-1 (1 µM) [22]. As expected, Mdivi-1 reversed
the defect in the mitochondrial network in Drp1 over-
expressing myotubes increasing both the mitochondrial
branches and the branch length (Fig. S4E). We also found,
accordingly to muscle, a significant reduction of Drp1 levels
in myotubes and an unchanged expression of KIF5B and
KLC1 (Fig. S4F). Consistently, Mdivi-1 reduced the motile
properties of mitochondria in Drp/MC myotubes with
respect to their net displacement (Fig. 4c and Video 4) and
the fluctuation of their instantaneous velocity (Fig. 4d).
Comparable to the 50% decrease in Drp1 levels, we
found a proportional reduction in Drp1:KLC1 PLA signal in
muscle sections (Fig. 4e) and fibres (Fig. S4G) of Drp/MC
mice treated with Mdivi-1, as well as a proportional
reduction in the amount of KLC1 co-immunoprecipitated
with Drp1 in Mdivi-1-treated muscle homogenates (Fig. 4f).
Both findings indicate that KLC1 is less sequestered by
Drp1 and likely more associated with KIF5B. Strikingly,
the KIF5B:α-tubulin PLA interactions were reduced after
Mdivi-1 exposure, confirming the presence of a less active
kinesin-1 (Fig. 4g and Fig. S4H).
Taken together, these data provide compelling evidence
that in Drp/MC mice cytosolic Drp1 binds KLC1, leading to
dissociation of the kinesin-1 tetramer and allowing KIF5B
to associate with MT to transport mitochondria.
Drp1 can affect desmin assembling promoting
mitochondrial repositioning
MT and MF networks were unaffected in Drp/MC mice,
however, the proper localisation of mitochondria is also
maintained by desmin IF; hence we explored their mor-
phology in Drp/MC mice. Muscle transversal sections of
WT mice showed that desmin IF were typically located
underneath the sarcolemma and at the level of Z-discs
(Fig. 5a, left panel), however, at P25 in Drp/MC mice some
desmin aggregates were found in the subsarcolemmal
region (Fig. 5a upper panels). This phenotype worsened
with age such that, in Drp/MC mice at P100, desmin was
massively accumulated in the subsarcolemmal region and
formed sarcoplasmic aggregates in most fibres (Fig. 5a
lower panel).
We also performed SDH staining and desmin immuno-
fluorescence which showed that sarcoplasmic desmin
aggregates were in mitochondria rubbed-out areas (Fig. 5b).
This desmin collapse was confirmed in single fibres
preparation. At P100, while WT fibres did not show any
overt abnormalities, substantial changes in the desmin pat-
tern were found in Drp/MC/PhAM fibres (Fig. 5c). At P25
the Drp/MC/PhAM phenotype was milder, displaying only
partial accumulation of desmin beneath the sarcolemma
(Fig. S5A).
Consistently with this, immunoblot analysis revealed a
significant increase in desmin protein levels in Drp/MC
muscle at P100 (Fig. 5d), while at P25 desmin expression
was unchanged (Fig. S5B). In line with the presence of
aggregates, an ~200 kDa band was detected specifically in
Drp1 overexpressing muscle, representing detergent-
resistant tetramers, i.e. a desmin insoluble fraction
(Fig. 5e). Desmin is subjected to many post-translational
modifications that cause disassembly of its network [42]
and in agreement with this, we detected high phosphor-
ylation of desmin at Ser-31 in Drp/MC muscle at P25
(Fig. 6a). We also carried out a time-course analysis and we
found phospho-Ser-31 positive aggregates at P7 that were
evident at P25 and P100 as well and were localised in the
subsarcolemmal region and in the centre of the fibres
(Fig. 6b). Cyclin-dependent kinase-1 (Cdk-1) is responsible
for this phosphorylation [43]: consistently, it was more
active in Drp/MC muscle at P7 (Fig. 6c). Along with des-
min, also Drp1 was phosphorylated at both P7 (Fig. 6d) and
P25 (Fig. 1a) in keeping with the notion that Cdk-1 also
drives the phosphorylation of Drp1 at Ser-616 [32]. These
results indicate that the higher activity of Cdk-1 in Drp/MC
mice leads to persistent desmin and Drp1 phosphorylations
that contribute to muscle phenotype.
After Mdivi-1 treatment, desmin pattern appeared
improved compared with untreated Drp/MC mice, with less
sarcoplasmic aggregates, even if its shape did not fully
Fig. 4 Mdivi-1 treatment reduces Drp1-KLC1 binding and mito-
chondrial movements. a Succinate dehydrogenase (SDH) staining of
TA muscle sections from Drp/MC mice treated or not with Mdivi-1
(12.5 mg/kg). Percentage of rubbed-out fibres were quantified and
shown as percentage of total fibres (n= 3 mice per condition) (scale
bar= 50 µm). b Representative immunoblotting of Drp1 and GAPDH
as loading control in TA lysates from WT and Drp/MC mice treated or
not with Mdivi-1. (n ≥ 3 mice per condition). c Stills from movies
showing the area occupied by mitochondria from Drp/MC myotubes
treated or not with Mdivi-1 at 10 s (magenta) and after 600 s (blue)
(scale bar= 5 µm). Displacement Index was calculated (n ≥ 3 inde-
pendent experiments). * vs untreated Drp/MC myotubes (**P < 0.01).
d Instantaneous velocities of mitochondria in selected ROI were
determined in Drp/MC myotubes treated or not with Mdivi-1 using
Mytoe software (n ≥ 3 independent experiments). e Representative
PLA Drp1:KLC1 (red puncta) on TA muscle sections from Drp/MC
mice treated or not with Mdivi-1. DAPI nuclear counterstaining (blue)
is provided (scale bar= 25 µm). PLA puncta were quantified and
shown as a percentage relative to untreated Drp/MC mice (n= 3 mice
per condition). f Co-immunoprecipitation of Drp1 and KLC1 in gas-
trocnemius lysates from Drp/MC mice treated or not with Mdivi-1.
Control immunoglobulins (cIgG) were used as IP negative control.
g Representative PLA KIF5B:α-Tubulin (red puncta) on TA muscle
sections from Drp/MC mice treated or not with Mdivi-1. DAPI
nuclear counterstaining (blue) is provided (scale bar= 25 µm). PLA
puncta were quantified and shown as a percentage relative to untreated
Drp/MC mice (n= 3 mice per condition). Values are expressed as
mean ± SEM. * vs untreated Drp/MC mice (*P < 0.05, **P < 0.01,
***P < 0.001).
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recover to match that of WT (Fig. 7a). Consistently the
presence of insoluble tetramers was reduced (Fig. 7b) as
well as the phosphorylation of desmin at Ser-31 (Fig. 7c)
with single muscle fibres showing a more striated outline
after Mdivi-1 treatment (Fig. S5C). These findings were
superimposable with the partial recovery of the mitochon-
drial network induced by Mdivi-1. However, the Drp1-
dependent desmin aggregation was not completely blunted
Fig. 5 Defective desmin network in Drp/MC mice. a Representative
desmin immunostaining (red) of TA sections from WT and Drp/MC
mice at P25 and P100. DAPI is used as nuclear staining (blue) (scale
bar= 25 μm). b Representative desmin immunostaining (red) and
SDH staining (grey) of TA sections from WT and Drp/MC mice at
P100. DAPI is used as nuclear staining (blue) (scale bar= 25 μm). c
Representative desmin immunostaining (red) of TA fibres from WT/
PhAM and Drp/MC/PhAM mice at P100. Mitochondrial network
(green) images are provided (scale bar= 10 μm). d Representative
immunoblotting of desmin in TA lysates from WT and Drp/MC mice
at P100. GAPDH has been used as a loading control. Desmin levels
were quantified and shown as fold change of WT (n ≥ 6 mice per
genotype). e Representative immunoblotting showing the 200-kDa
bands detected by the desmin antibody corresponding to a detergent-
resistant tetramers in TA lysates from WT and Drp/MC mice at P100.
GAPDH has been used as a loading control. Values are expressed as
mean ± SEM. * vs WT (**P < 0.01).
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as shown by persisting phospho-desmin Ser-31 aggregates
(Fig. 7d) and the unfolded protein response, enhanced in
Drp/MC mice [15], was still active (Fig. S5D, E), thus
sustaining the partial effects of Mdivi-1 administration.
The muscular phenotype of the Drp/MC mice resembles
that observed in the central core disease, characterised by
core areas without COX activity (Fig. 8a, left panel), and
the myofibrillar myopathy characterised by desmin
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accumulation and aggregation (Fig. 8b, left panel). Because
of this similarity, we analysed human muscle biopsies from
patients affected by central core disease or myofibrillar
myopathy. In both conditions Drp1 was overexpressed
compared with healthy controls (Fig. 8a, b, right panels),
suggesting a possible role of Drp1 in establishing the
phenotype.
Discussion
Using a specific skeletal muscle transgenic model we report
on a hitherto unknown function of Drp1, i.e. its role in
controlling both mitochondrial repositioning and desmin
assembling.
Defects in desmin assembly or desmin loss cause sub-
sarcolemmal mitochondria clumping [12, 44–46]. This
phenomenon occurs in Drp/MC mice leading to fibres
characterised by focal depletion of mitochondria from their
centre. In Drp/MC mice desmin does not have its typical
striated pattern, being aggregated in the subsarcolemmal
region and accumulated in mitochondria rubbed-out areas,
resembling the pattern observed in some myofibrillar
myopathies [45, 47]. The presence of insoluble tetramers
may be explained by an inefficient desmin assembling
leading to the collapse and aggregation of filaments [44]. It
is well established that IF are dynamic structures and
reversible phosphorylation is a mechanism that plausibly
maintains this dynamism affecting its assembling and dis-
assembling [48, 49]. In line with this, we found that in Drp/
MC mice desmin was hyperphosphorylated in Ser-31 by a
hyperactivated Cdk-1. This led to persistent phosphoryla-
tion of both desmin and Drp1 and resulted in desmin dis-
assembling and Drp1 activation. Desmin preserves
mitochondria in close proximity to myofibrils and promotes
the transfer of the energy. It is able to sense and respond to
stress regulating many processes including the gene
expression, thus desmin can be considered a mechanosensor
and transducer of signals to the nucleus [42, 48, 50].
Moreover, desmin disruption compromises the cross-talk
between mitochondria and other organelles affecting mito-
chondrial biogenesis and function [48]. At P7 we observed
induction of fission and desmin phospho-Ser-31 positive
aggregates, while the mitochondrial repositioning, with
subsarcolemmal clumping, and the impaired mitochondrial
biogenesis occurred at P25 in Drp/MC mice. This suggests
that an early desmin disruption could compromise the
mechanotransduction system affecting both the biogenesis
and the maintenance of the fissioned-mitochondria in the
proper position, driving upregulation of kinesin-1 and
mitochondrial repositioning at sarcolemma.
The investigations on desmin alterations allowed us to
uncover the direct action of Drp1 on mitochondrial dis-
tribution. Mitochondrial motility is a feature of many
eukaryotic cells and this motility permits the mitochondria
to be distributed in view of local energy use. In neurons as
well as in muscle, much of this motility is MT-based and
requires kinesins as motor proteins [8, 39]. Kinesin-1 is a
tetramer consisting of kinesin heavy chains and kinesin
light chains [18] with the heavy chain KIF5B primarily
involved in the mitochondria movements along MT in the
muscle [8]. In muscle, Drp1 is able to control kinesin-1
complex activation.
Drp1 promotes fission and mediates the mobilisation of
mitochondria along the MT bound to KLC1; we found that
the Drp1-KLC1 complex released KIF5B allowing its
association with MT to transport mitochondria and
increased the speed and distance they travelled individually.
The MT binding assay and PLA experiments clearly
established that the active form of kinesin-1 involved only
KIF5B and not the tetramer, excluding situations previously
described in which kinesin activation is mediated by con-
formational changes and association with binding partners
[40, 51]. Therefore the mitochondria repositioning observed
in Drp/MC mice does not require KLC1; this non-
conventional kinesin heavy chain-based transport has been
previously reported also in Neurospora crassa [52], neu-
ronal dendrites [53], and axons [39]. Our results describe
for the first time this mechanism in muscle and identify
Drp1 as a new regulator of the complex in vivo. The
mechanism of kinesin-1 activation is dependent on Drp1
levels, indeed we found that KIF5B-MT interaction was
increased in Drp1-overexpressing condition, while it
decreased, proportionally to Drp1 reduction, after Mdivi-1-
treatment. However, the positive effects of Mdivi-1 were
only partial because it did not restore Drp1 levels to those
observed under basal conditions. Whereas the efficacy of
Mdivi-1 as a Drp1 inhibitor has recently been challenged
Fig. 6 Cdk-1 activation drives desmin phosphorylation at Ser-31
resulting in its disassembling. a Representative immunoblotting of
phospho-desmin on serine-31 (p-Desmin-S31) in gastrocnemius
lysates from WT and Drp/MC mice at P25. Total desmin has been
used as loading control. Phospho-desmin levels normalised on total
desmin were quantified and shown as fold change of WT (n= 8 mice
per genotype). b Representative p-Desmin-S31 (green) and desmin
(red) immunostainings of TA sections from WT and Drp/MC mice at
P7, P25 and P100. DAPI is used as nuclear staining (blue) (scale bar=
10 μm). c Representative immunoblotting of phospho-Cdk-1 on
Threonine 161 (p-Cdk-1-T161) in gastrocnemius lysates from WT and
Drp/MC mice at P7. Total Cdk-1 has been used as loading control.
Phospho-Cdk-1 levels normalised on total Cdk-1 were quantified and
shown as fold change of WT (n= 8 mice per genotype). d Repre-
sentative immunoblotting of p-Drp1-S616 in gastrocnemius lysates
from WT and Drp/MC mice at P7. Total Drp1 has been used as
loading control. Phospho-Drp1 levels normalised on total Drp1 were
quantified and shown as fold change of WT (n= 5 mice per genotype).
Values are expressed as mean ± SEM. * vs WT mice (*P < 0.05,
**P < 0.01, ***P < 0.001).
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Fig. 7 Mdivi-1 treatment improves desmin network abnormalities
in Drp/MC mice. a Representative desmin immunostaining (red) of
TA sections from WT and Drp/MC mice treated or not with Mdivi-1.
DAPI is used as nuclear staining (blue) (upper panel scale bars=
10 μm; lower panel scale bars= 50 μm). Fibres containing
desmin clusters were quantified and shown as percentage of total fibres
(n= 3 mice per condition). b Representative immunoblotting of des-
min in TA lysates from WT and Drp/MC mice treated or not with
Mdivi-1. Both desmin tetramers and monomers signals are shown.
GAPDH has been used as a loading control. c Representative immu-
noblotting of p-Desmin-S31 in gastrocnemius lysates from Drp/MC
mice treated or not with Mdivi-1. Total desmin has been used as
loading control. Phospho-desmin levels normalised on total desmin
were quantified and shown as fold change of Drp/MC (n ≥ 3 mice per
genotype). d Representative p-Desmin-S31 (green) and desmin
(red) immunostainings of TA sections from Drp/MC mice treated or
not with Mdivi-1. DAPI is used as nuclear staining (blue) (scale bar=
25 μm). Fibres containing phospho-desmin aggregates were quantified
and shown as percentage of total fibres (n= 3 mice per condition).
Values are expressed as mean ± SEM. * vs untreated Drp/MC mice
(*P < 0.05, ***P < 0.001).
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[54], several lines of evidence support this activity
[41, 55, 56] showing that Mdivi-1 reduces Drp1 levels,
prevents mitochondrial fragmentation, enhances fusion and
promotes the formation of mitochondrial network and we
confirm these findings. In agreement with mitochondrial
improvements, Mdivi-1 ameliorated also desmin pattern in
Drp/MC muscle, decreasing the accumulation of insoluble
sarcoplasmic tetramers and consistently its phosphorylation
in Ser-31. Desmin might be involved in the control of
proper fusion-fission events [50]; Mdivi-1 can not prevent
Cdk-1 activation that occurs at P7, rather it inhibits fission
and establishes a direct link between mitochondrial fission
and desmin phosphorylation. However, as Mdivi-1 did not
fully restore mitochondrial network, it did not allow a full
recovery of desmin assembling. These results confirm that
desmin collapse in Drp/MC mice depends on its phos-
phorylation on Ser-31, that requires both Cdk-1 activation
and mitochondrial fission. These events compromise the
stability of mitochondrial network promoting its remodel-
ling mediated by MT-dependent trafficking. We also sug-
gest that Drp1 levels play a central role in coordinating
mitochondrial repositioning, coupling to KLC1 and acti-
vating KIF5B. This unravels a hitherto unknown action of
Drp1 as a modulator of organelle movements. This new
mechanism could be relevant in some human conditions,
such as central core disease and myofibrillar myopathy. We
found that Drp1 was upregulated in both conditions sug-
gesting its possible involvement in establishing the pheno-
type. The extensive characterisation of the role of Drp1 in
these two muscular disorders may unravel novel pathogenic
mechanisms responsible for muscular degeneration and
provide possible novel therapeutic targets.
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Fig. 8 Central core and myofibrillar myopathy show high Drp1
expression. a Central Core (CC) myopathy left panel: COX staining in
two human muscle samples showing central area without or reduced
COX activity (b–c). (a) COX activity in normal human muscle sam-
ples. Scale Bar (a: 50 µm, b–c: 25 µm). Right panel: Drp1 immuno-
blotting in muscle homogenates from controls and CC human biopsies.
b Myofibrillar myopathy (MFM) left panel: desmin immunostaining
showing desmin accumulation in two human muscle samples (white
arrows) (b–c). (a) Desmin immunostaining in normal human muscle
sample. Scale Bar (a: 40 µm, b–c: 25 µm). Right panel: Drp1 immu-
noblotting in muscle homogenates from controls and MFM human
biopsies.
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